Evidence map›Paper›PMID 27859310›Full record

ReviewThe Journal of pathology2017

The pathobiology of vascular malformations: insights from human and model organism genetics.

Sarah E Wetzel-Strong, Matthew R Detter, Douglas A Marchuk

Abstract readReview
In one paragraph

Review in The Journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Central conducting lymphatic anomaly: from bench to bedside.The Journal of clinical investigation · 2024
    Review
  17. Article
  18. Article
  19. Association Between theInternational journal of general medicine · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sarah E Wetzel-StrongDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Matthew R DetterDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Douglas A MarchukDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Duke University · USDuke Medical Center · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Somatic mutation(s) and cellular changes in CCM pathogenesisP01NS092521 · NINDS · DUKE UNIVERSITY · PI KAHN, MARK L · 2015 to 2024
$12.9M
MULTIDISCIPLINARY HEART &VASCULAR DISEASEST32HL007101 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 1985 to 2020
$9.8M
Rock Inhibition as Therapy for Cerebral Cavernous MalformationR01NS077957 · NINDS · UNIVERSITY OF CHICAGO · PI AWAD, ISSAM A, MARCHUK, DOUGLAS A. · 2012 to 2016
$2.3M
Functional Characterization of the GNAQ somatic mutation causing Sturge Weber syndromeR21NS091589 · NINDS · DUKE UNIVERSITY · PI MARCHUK, DOUGLAS A. · 2015 to 2016
$437k
NHLBI NIH HHS T32 HL007101NIGMS NIH HHS T32 GM007171NINDS NIH HHS P01 NS092521NINDS NIH HHS R01 NS077957NINDS NIH HHS R21 NS091589
6 · The paper itself

Abstract

Vascular malformations may arise in any of the vascular beds present in the human body. These lesions vary in location, type, and clinical severity of the phenotype. In recent years, the genetic basis of several vascular malformations has been elucidated. This review will consider how the identification of the genetic factors contributing to different vascular malformations, with subsequent functional studies in animal models, has provided a better understanding of these factors that maintain vascular integrity in vascular beds, as well as their role in the pathogenesis of vascular malformations. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Indexed as

Genetic Predisposition to DiseaseOrganisms, Genetically ModifiedAnimalsEndothelial CellsHumansModels, AnimalTransforming Growth Factor beta2Vascular MalformationsTGFB2 protein, humanTransforming Growth Factor beta2arterial tortuosity syndromeblue rubber bleb naevus syndromeCADASIL/CARASILcapillary malformation-arteriovenous malformationcerebral cavernous malformationglomuvenous malformationshereditary haemorrhagic telangiectasiaKlippel-Trenaunay syndromeLoeys-Dietz syndromemoyamoya diseaseParkes Weber syndromeSturge-Weber syndromevenous malformations

Identifiers

PMID27859310
PMCPMC5167654
OpenAlexW2552252520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.